Reimbursement Pathway for Fluorescence Imaging and Detection of Bacteria

Reimbursement Pathway
for Fluorescence Imaging
and Detection of Bacteria

The American Medical Association (AMA) has
issued two new CPT category lll codes to enable a
reimbursement pathway for point-of-care real-time
fluorescence wound imaging for bacterial presence,
location and load using the MolecuLight i:X® procedure:

  • 0598T Noncontact real-time fluorescence wound
    imaging, for bacterial presence, location, and load,
    per session; first anatomic site
    (e.g. lower extremity),
    and
  • 0599T each additional anatomic site (e.g. upper
    extremity) (in addition to code for primary procedure)
    (Use 0599T in conjunction with 0598T)

Point-of-care fluorescence imaging of wounds is
achieved using MolecuLight’s handheld fluorescence
imaging device, the i:X.

These CPT codes will be active on July 1, 2020.

 

Recent Articles
“Share New Codes with Your Clinical and Revenue Cycle Teams”
Today’s Wound Clinic, Feb. 3, 2020
Kathleen D. Schaum, MS


DISCLAIMER: Coding, coverage, payment, and billing information provided by MolecuLight Corp. is based on third party sources and is subject to change. MolecuLight Corp. cannot guarantee that the use of any particular codes will result in coverage or payment at any specific level. The information provided in this document does not constitute reimbursement or legal advice, and is not a substitute for detailed guidance from the patient’s third party payer. Providers are responsible for determining correct coding and for submitting accurate claims.